Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland.
about
Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data.Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.Costs of Managing Patients with Diabetes in a Large Health Maintenance Organization in Israel: A Retrospective Cohort Study.Prevalence and pattern of co morbidity among type2 diabetics attending urban primary healthcare centers at Bhubaneswar (India).Intensity of treatment in Swiss cancer patients at the end-of-life.Multimorbidity and the primary healthcare perspective.
P2860
Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Estimating the prevalence of c ...... betes mellitus in Switzerland.
@ast
Estimating the prevalence of c ...... betes mellitus in Switzerland.
@en
Estimating the prevalence of c ...... betes mellitus in Switzerland.
@nl
type
label
Estimating the prevalence of c ...... betes mellitus in Switzerland.
@ast
Estimating the prevalence of c ...... betes mellitus in Switzerland.
@en
Estimating the prevalence of c ...... betes mellitus in Switzerland.
@nl
prefLabel
Estimating the prevalence of c ...... betes mellitus in Switzerland.
@ast
Estimating the prevalence of c ...... betes mellitus in Switzerland.
@en
Estimating the prevalence of c ...... betes mellitus in Switzerland.
@nl
P2093
P2860
P356
P1476
Estimating the prevalence of c ...... abetes mellitus in Switzerland
@en
P2093
Carola A Huber
Oliver Reich
Peter Diem
P2860
P304
P356
10.2147/DMSO.S69520
P577
2014-10-01T00:00:00Z